Recent Analyst Stock Rating News
The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.Get Started for Free
Andrew Berens is an analyst at Leerink Partners. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 03/25/2025
| Buy Now | Get Alert | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 03/21/2025 | ELEV | Buy Now | Elevation Oncology | $0.28 | 254.11% | Andrew Berens49% | $9 → $1 | Downgrade | Outperform → Market Perform | Get Alert |
| 12/05/2024 | OKUR | Buy Now | OnKure Therapeutics | $5.10 | 547.06% | Andrew Berens49% | → $33 | Initiates | → Outperform | Get Alert |
| 11/07/2024 | ZYME | Buy Now | Zymeworks | $12.80 | 95.31% | Andrew Berens49% | $10 → $25 | Upgrade | Market Perform → Outperform | Get Alert |
| 10/21/2024 | GILD | Buy Now | Gilead Sciences | $107.89 | -11.02% | Andrew Berens49% | $74 → $96 | Upgrade | Market Perform → Outperform | Get Alert |
| 09/27/2024 | AGIO | Buy Now | Agios Pharmaceuticals | $30.50 | 83.61% | Andrew Berens49% | $60 → $56 | Downgrade | Outperform → Market Perform | Get Alert |
| 08/16/2024 | VIRX | Buy Now | Viracta Therapeutics | $0.03 | 11900% | Andrew Berens49% | $5 → $3 | Downgrade | Outperform → Market Perform | Get Alert |
| 07/22/2024 | CELC | Buy Now | Celcuity | $10.51 | 175.93% | Andrew Berens49% | → $29 | Initiates | → Outperform | Get Alert |
| 05/06/2024 | BPMC | Buy Now | Blueprint Medicines | $93.08 | 4.21% | Andrew Berens49% | $50 → $97 | Upgrade | Underperform → Market Perform | Get Alert |
| 04/01/2024 | NUVL | Buy Now | Nuvalent | $74.98 | 46.71% | Andrew Berens49% | $69 → $110 | Upgrade | Market Perform → Outperform | Get Alert |
| 12/13/2023 | INCY | Buy Now | Incyte | $62.08 | 25.64% | Andrew Berens49% | → $78 | Upgrade | Market Perform → Outperform | Get Alert |
| 11/07/2023 | MRTX | Buy Now | Mirati Therapeutics | — | — | Andrew Berens49% | $78 → $58 | Downgrade | Outperform → Market Perform | Get Alert |
| 08/15/2023 | VIRX | Buy Now | Viracta Therapeutics | $0.03 | 19900% | Andrew Berens49% | $10 → $5 | Maintains | Outperform | Get Alert |
| 06/05/2023 | BPMC | Buy Now | Blueprint Medicines | $93.08 | -53.8% | Andrew Berens49% | $48 → $43 | Downgrade | Market Perform → Underperform | Get Alert |
| 05/30/2023 | ELEV | Buy Now | Elevation Oncology | $0.28 | 2732.86% | Andrew Berens49% | $5 → $8 | Upgrade | Market Perform → Outperform | Get Alert |
| 05/16/2023 | CTIC | Buy Now | CTI BioPharma | — | — | Andrew Berens49% | $13 → $9.1 | Downgrade | Outperform → Market Perform | Get Alert |
| 05/08/2023 | VIRX | Buy Now | Viracta Therapeutics | $0.03 | 43900% | Andrew Berens49% | $11 → $11 | Maintains | Outperform | Get Alert |
| 04/17/2023 | MRUS | Buy Now | Merus | $46.98 | 2.17% | Andrew Berens49% | $35 → $48 | Maintains | Outperform | Get Alert |
| 03/20/2023 | INCY | Buy Now | Incyte | $62.08 | -3.35% | Andrew Berens49% | $63 → $60 | Maintains | Underperform | Get Alert |
| 02/24/2023 | BPMC | Buy Now | Blueprint Medicines | $93.08 | -59.17% | Andrew Berens49% | $45 → $38 | Maintains | Market Perform | Get Alert |
| 02/08/2023 | INCY | Buy Now | Incyte | $62.08 | 1.48% | Andrew Berens49% | → $63 | Reiterates | → Underperform | Get Alert |
| 02/08/2023 | DCPH | Buy Now | Deciphera Pharmaceuticals | — | — | Andrew Berens49% | → $30 | Reiterates | → Outperform | Get Alert |
| 02/07/2023 | DCPH | Buy Now | Deciphera Pharmaceuticals | — | — | Andrew Berens49% | $28 → $30 | Maintains | Outperform | Get Alert |
| 02/06/2023 | SGEN | Buy Now | Seagen | — | — | Andrew Berens49% | $162 → $141 | Downgrade | Outperform → Market Perform | Get Alert |
| 01/20/2023 | BGNE | Buy Now | BeiGene | — | — | Andrew Berens49% | $236 → $300 | Maintains | Outperform | Get Alert |
| 01/20/2023 | SGEN | Buy Now | Seagen | — | — | Andrew Berens49% | $160 → $162 | Maintains | Outperform | Get Alert |
| 01/20/2023 | ZYME | Buy Now | Zymeworks | $12.80 | -21.88% | Andrew Berens49% | $8 → $10 | Maintains | Market Perform | Get Alert |
| 01/09/2023 | ELEV | Buy Now | Elevation Oncology | $0.28 | 254.11% | Andrew Berens49% | $2 → $1 | Maintains | Market Perform | Get Alert |
| 01/05/2023 | COGT | Buy Now | Cogent Biosciences | $7.02 | 184.9% | Andrew Berens49% | $18 → $20 | Maintains | Outperform | Get Alert |
| 01/04/2023 | DCPH | Buy Now | Deciphera Pharmaceuticals | — | — | Andrew Berens49% | $25 → $28 | Maintains | Outperform | Get Alert |
| 12/14/2022 | MRTX | Buy Now | Mirati Therapeutics | — | — | Andrew Berens49% | $85 → $75 | Maintains | Outperform | Get Alert |
| 12/13/2022 | NRIX | Buy Now | Nurix Therapeutics | $12.66 | 121.17% | Andrew Berens49% | $37 → $28 | Maintains | Outperform | Get Alert |
| 12/12/2022 | BGNE | Buy Now | BeiGene | — | — | Andrew Berens49% | $210 → $236 | Maintains | Outperform | Get Alert |
| 12/08/2022 | MRTX | Buy Now | Mirati Therapeutics | — | — | Andrew Berens49% | $102 → $85 | Maintains | Outperform | Get Alert |
| 11/23/2022 | ARVN | Buy Now | Arvinas | $8.16 | 757.84% | Andrew Berens49% | $74 → $70 | Maintains | Outperform | Get Alert |
| 11/22/2022 | ARVN | Buy Now | Arvinas | $8.16 | 806.86% | Andrew Berens49% | $89 → $74 | Maintains | Outperform | Get Alert |
| 11/17/2022 | COGT | Buy Now | Cogent Biosciences | $7.02 | 156.41% | Andrew Berens49% | $20 → $18 | Maintains | Outperform | Get Alert |
| 11/14/2022 | AZN | Buy Now | AstraZeneca | $72.60 | 8.81% | Andrew Berens49% | $78 → $79 | Maintains | Outperform | Get Alert |
| 11/11/2022 | AZN | Buy Now | AstraZeneca | $72.60 | 7.43% | Andrew Berens49% | $75 → $78 | Maintains | Outperform | Get Alert |
| 11/10/2022 | VIRX | Buy Now | Viracta Therapeutics | $0.03 | 43900% | Andrew Berens49% | → $11 | Maintains | Outperform | Get Alert |
| 11/10/2022 | ZNTL | Buy Now | Zentalis Pharma | $1.87 | 1343.85% | Andrew Berens49% | $42 → $27 | Maintains | Outperform | Get Alert |
| 11/10/2022 | BGNE | Buy Now | BeiGene | — | — | Andrew Berens49% | $200 → $210 | Maintains | Outperform | Get Alert |
| 11/09/2022 | MRTX | Buy Now | Mirati Therapeutics | — | — | Andrew Berens49% | $111 → $102 | Maintains | Outperform | Get Alert |
| 11/07/2022 | ELEV | Buy Now | Elevation Oncology | $0.28 | 608.22% | Andrew Berens49% | $11 → $2 | Downgrade | Outperform → Market Perform | Get Alert |
| 11/04/2022 | MRUS | Buy Now | Merus | $46.98 | -25.5% | Andrew Berens49% | $39 → $35 | Maintains | Outperform | Get Alert |
| 11/02/2022 | BPMC | Buy Now | Blueprint Medicines | $93.08 | -44.13% | Andrew Berens49% | $57 → $52 | Maintains | Market Perform | Get Alert |
| 10/24/2022 | AVEO | Buy Now | AVEO Pharmaceuticals | — | — | Andrew Berens49% | — | Downgrade | Outperform → Market Perform | Get Alert |
| 10/21/2022 | ZYME | Buy Now | Zymeworks BC | $12.80 | -37.5% | Andrew Berens49% | $19 → $8 | Downgrade | Outperform → Market Perform | Get Alert |
| 10/17/2022 | CTIC | Buy Now | CTI BioPharma | — | — | Andrew Berens49% | → $13 | Initiates | → Outperform | Get Alert |
| 10/13/2022 | MRUS | Buy Now | Merus | $46.98 | -16.99% | Andrew Berens49% | $33 → $39 | Maintains | Outperform | Get Alert |
| 10/13/2022 | BGNE | Buy Now | BeiGene | — | — | Andrew Berens49% | $177 → $200 | Upgrade | Market Perform → Outperform | Get Alert |
| 09/13/2022 | SGEN | Buy Now | Seagen | — | — | Andrew Berens49% | $152 → $160 | Maintains | Outperform | Get Alert |
| 09/12/2022 | DCPH | Buy Now | Deciphera Pharmaceuticals | — | — | Andrew Berens49% | $21 → $25 | Maintains | Outperform | Get Alert |
| 08/18/2022 | BPMC | Buy Now | Blueprint Medicines | $93.08 | -38.76% | Andrew Berens49% | $65 → $57 | Maintains | Market Perform | Get Alert |
| 08/15/2022 | SGEN | Buy Now | Seagen | — | — | Andrew Berens49% | $159 → $152 | Maintains | Outperform | Get Alert |
| 08/11/2022 | HOOK | Buy Now | HOOKIPA Pharma | $1.20 | 149.98% | Andrew Berens49% | $40 → $30 | Maintains | Outperform | Get Alert |
| 08/10/2022 | ZNTL | Buy Now | Zentalis Pharma | $1.87 | 2145.99% | Andrew Berens49% | $67 → $42 | Maintains | Outperform | Get Alert |
| 08/09/2022 | GBT | Buy Now | Global Blood Therapeutics | — | — | Andrew Berens49% | → $68.5 | Downgrade | Outperform → Market Perform | Get Alert |
| 08/05/2022 | AGIO | Buy Now | Agios Pharmaceuticals | $30.50 | 21.31% | Andrew Berens49% | $33 → $37 | Maintains | Outperform | Get Alert |
| 08/05/2022 | DCPH | Buy Now | Deciphera Pharmaceuticals | — | — | Andrew Berens49% | $15 → $21 | Maintains | Outperform | Get Alert |
| 08/05/2022 | ARVN | Buy Now | Arvinas | $8.16 | 990.69% | Andrew Berens49% | $91 → $89 | Maintains | Outperform | Get Alert |
| 08/03/2022 | BPMC | Buy Now | Blueprint Medicines | $93.08 | -30.17% | Andrew Berens49% | $56 → $65 | Maintains | Market Perform | Get Alert |
| 07/27/2022 | AGIO | Buy Now | Agios Pharmaceuticals | $30.50 | 8.2% | Andrew Berens49% | → $33 | Upgrade | Market Perform → Outperform | Get Alert |
| 07/20/2022 | INCY | Buy Now | Incyte | $62.08 | 1.48% | Andrew Berens49% | $58 → $63 | Maintains | Underperform | Get Alert |
| 07/01/2022 | BPMC | Buy Now | Blueprint Medicines | $93.08 | -39.84% | Andrew Berens49% | $60 → $56 | Maintains | Market Perform | Get Alert |
| 06/13/2022 | TPTX | Buy Now | Turning Point | — | — | Andrew Berens49% | $101 → $76 | Downgrade | Outperform → Market Perform | Get Alert |
| 06/13/2022 | BPMC | Buy Now | Blueprint Medicines | $93.08 | -35.54% | Andrew Berens49% | $82 → $60 | Maintains | Market Perform | Get Alert |
| 06/13/2022 | COGT | Buy Now | Cogent Biosciences | $7.02 | 113.68% | Andrew Berens49% | $14 → $15 | Maintains | Outperform | Get Alert |
| 06/06/2022 | SGEN | Buy Now | Seagen | — | — | Andrew Berens49% | $155 → $159 | Maintains | Outperform | Get Alert |
| 05/27/2022 | ZYME | Buy Now | Zymeworks | $12.80 | 48.44% | Andrew Berens49% | $18 → $19 | Maintains | Outperform | Get Alert |
| 05/27/2022 | MRTX | Buy Now | Mirati Therapeutics | — | — | Andrew Berens49% | $164 → $111 | Maintains | Outperform | Get Alert |
| 05/27/2022 | FMTX | Buy Now | Forma Therapeutics Hldgs | — | — | Andrew Berens49% | $25 → $23 | Maintains | Outperform | Get Alert |
| 05/17/2022 | AGIO | Buy Now | Agios Pharmaceuticals | $30.50 | 8.2% | Andrew Berens49% | $30 → $33 | Maintains | Market Perform | Get Alert |
| 05/13/2022 | CGEM | Buy Now | Cullinan Oncology | $8.30 | 201.2% | Andrew Berens49% | $36 → $25 | Maintains | Outperform | Get Alert |
| 05/11/2022 | TPTX | Buy Now | Turning Point | — | — | Andrew Berens49% | $107 → $101 | Maintains | Outperform | Get Alert |
| 05/05/2022 | CMPX | Buy Now | Compass Therapeutics | $2.17 | 406.91% | Andrew Berens49% | $9 → $11 | Maintains | Outperform | Get Alert |
| 05/04/2022 | INCY | Buy Now | Incyte | $62.08 | -6.57% | Andrew Berens49% | $56 → $58 | Maintains | Underperform | Get Alert |
| 05/04/2022 | AZN | Buy Now | AstraZeneca | $72.60 | 3.3% | Andrew Berens49% | $70 → $75 | Maintains | Outperform | Get Alert |
| 04/12/2022 | ZNTL | Buy Now | Zentalis Pharma | $1.87 | 3482.89% | Andrew Berens49% | $78 → $67 | Maintains | Outperform | Get Alert |
| 03/17/2022 | BGNE | Buy Now | BeiGene | — | — | Andrew Berens49% | $300 → $177 | Downgrade | Outperform → Market Perform | Get Alert |
| 02/28/2022 | BGNE | Buy Now | BeiGene | — | — | Andrew Berens49% | $334 → $300 | Maintains | Outperform | Get Alert |
| 02/24/2022 | AZN | Buy Now | AstraZeneca | $72.60 | -3.59% | Andrew Berens49% | $65 → $70 | Maintains | Outperform | Get Alert |
| 02/22/2022 | AGIO | Buy Now | Agios Pharmaceuticals | $30.50 | -1.64% | Andrew Berens49% | $32 → $30 | Maintains | Market Perform | Get Alert |
| 02/18/2022 | ARVN | Buy Now | Arvinas | $8.16 | 1015.2% | Andrew Berens49% | $97 → $91 | Maintains | Outperform | Get Alert |
| 02/17/2022 | BPMC | Buy Now | Blueprint Medicines | $93.08 | -11.9% | Andrew Berens49% | $93 → $82 | Downgrade | Outperform → Market Perform | Get Alert |
| 02/16/2022 | HOOK | Buy Now | HOOKIPA Pharma | $1.20 | 233.31% | Andrew Berens49% | $30 → $40 | Maintains | Outperform | Get Alert |
| 02/10/2022 | SGEN | Buy Now | Seagen | — | — | Andrew Berens49% | $179 → $155 | Maintains | Outperform | Get Alert |
| 02/09/2022 | INCY | Buy Now | Incyte | $62.08 | -9.79% | Andrew Berens49% | $60 → $56 | Downgrade | Market Perform → Underperform | Get Alert |
| 01/12/2022 | BPMC | Buy Now | Blueprint Medicines | $93.08 | 28.92% | Andrew Berens49% | $132 → $120 | Maintains | Outperform | Get Alert |
| 12/21/2021 | GBT | Buy Now | Global Blood Therapeutics | — | — | Andrew Berens49% | $56 → $53 | Maintains | Outperform | Get Alert |
| 12/20/2021 | CMPX | Buy Now | Compass Therapeutics | $2.17 | 453% | Andrew Berens49% | → $12 | Initiates | → Outperform | Get Alert |
| 12/17/2021 | ZNTL | Buy Now | Zentalis Pharma | $1.87 | 5087.17% | Andrew Berens49% | $89 → $97 | Maintains | Outperform | Get Alert |
| 12/14/2021 | GBT | Buy Now | Global Blood Therapeutics | — | — | Andrew Berens49% | $54 → $56 | Maintains | Outperform | Get Alert |
| 12/10/2021 | ZYME | Buy Now | Zymeworks | $12.80 | — | Andrew Berens49% | — | Upgrade | Market Perform → Outperform | Get Alert |
| 12/10/2021 | ZNTL | Buy Now | Zentalis Pharma | $1.87 | 4659.36% | Andrew Berens49% | $84 → $89 | Maintains | Outperform | Get Alert |
| 11/23/2021 | AURA | Buy Now | Aura Biosciences | $7.08 | 464.97% | Andrew Berens49% | → $40 | Initiates | → Outperform | Get Alert |
| 11/18/2021 | AGIO | Buy Now | Agios Pharmaceuticals | $30.50 | 37.7% | Andrew Berens49% | $50 → $42 | Maintains | Market Perform | Get Alert |
| 11/12/2021 | FMTX | Buy Now | Forma Therapeutics Hldgs | — | — | Andrew Berens49% | $54 → $40 | Maintains | Outperform | Get Alert |
| 11/10/2021 | ZYME | Buy Now | Zymeworks | $12.80 | 110.94% | Andrew Berens49% | $28 → $27 | Maintains | Market Perform | Get Alert |
| 11/10/2021 | HOOK | Buy Now | HOOKIPA Pharma | $1.20 | 733.26% | Andrew Berens49% | $280 → $100 | Maintains | Outperform | Get Alert |
| 11/04/2021 | ZYME | Buy Now | Zymeworks | $12.80 | 118.75% | Andrew Berens49% | $43 → $28 | Maintains | Market Perform | Get Alert |
| 11/01/2021 | THRX | Buy Now | Theseus Pharmaceuticals | — | — | Andrew Berens49% | → $28 | Initiates | → Outperform | Get Alert |
| 10/27/2021 | NRIX | Buy Now | Nurix Therapeutics | $12.66 | 405.53% | Andrew Berens49% | $50 → $64 | Maintains | Outperform | Get Alert |
| 10/27/2021 | SGEN | Buy Now | Seagen | — | — | Andrew Berens49% | $190 → $200 | Maintains | Outperform | Get Alert |
| 10/14/2021 | ARVN | Buy Now | Arvinas | $8.16 | 1309.31% | Andrew Berens49% | → $115 | Initiates | → Outperform | Get Alert |
| 10/14/2021 | CCCC | Buy Now | C4 Therapeutics | $2.18 | 2973.39% | Andrew Berens49% | → $67 | Initiates | → Outperform | Get Alert |
| 10/14/2021 | NRIX | Buy Now | Nurix Therapeutics | $12.66 | 294.94% | Andrew Berens49% | → $50 | Initiates | → Outperform | Get Alert |
| 10/14/2021 | GLUE | Buy Now | Monte Rosa Therapeutics | $5.78 | 246.02% | Andrew Berens49% | → $20 | Initiates | → Market Perform | Get Alert |
| 10/14/2021 | BGNE | Buy Now | BeiGene | — | — | Andrew Berens49% | $417 → $414 | Maintains | Outperform | Get Alert |
| 10/08/2021 | MRUS | Buy Now | Merus | $46.98 | -4.21% | Andrew Berens49% | $33 → $45 | Maintains | Outperform | Get Alert |
| 09/27/2021 | AZN | Buy Now | AstraZeneca | $72.60 | 0.55% | Andrew Berens49% | $71 → $73 | Maintains | Outperform | Get Alert |
| 09/23/2021 | INCY | Buy Now | Incyte | $62.08 | 6.31% | Andrew Berens49% | $67 → $66 | Upgrade | Underperform → Market Perform | Get Alert |
| 09/22/2021 | SGEN | Buy Now | Seagen | — | — | Andrew Berens49% | $192 → $190 | Maintains | Outperform | Get Alert |
| 09/21/2021 | MRTX | Buy Now | Mirati Therapeutics | — | — | Andrew Berens49% | $195 → $205 | Maintains | Outperform | Get Alert |
| 09/20/2021 | TNGX | Buy Now | Tango Therapeutics | $1.64 | 1424.39% | Andrew Berens49% | → $25 | Initiates | → Outperform | Get Alert |
| 09/20/2021 | AZN | Buy Now | AstraZeneca | $72.60 | -2.21% | Andrew Berens49% | $69 → $71 | Maintains | Outperform | Get Alert |
| 08/04/2021 | AZN | Buy Now | AstraZeneca | $72.60 | -4.96% | Andrew Berens49% | $63 → $69 | Maintains | Outperform | Get Alert |
| 08/04/2021 | INCY | Buy Now | Incyte | $62.08 | 7.93% | Andrew Berens49% | $70 → $67 | Maintains | Underperform | Get Alert |
| 07/20/2021 | ELEV | Buy Now | Elevation Oncology | $0.28 | 6982.15% | Andrew Berens49% | → $20 | Initiates | → Outperform | Get Alert |
| 07/16/2021 | AZN | Buy Now | AstraZeneca | $72.60 | -13.23% | Andrew Berens49% | $64 → $63 | Maintains | Outperform | Get Alert |
| 06/17/2021 | BPMC | Buy Now | Blueprint Medicines | $93.08 | 47.19% | Andrew Berens49% | $127 → $137 | Maintains | Outperform | Get Alert |
| 06/14/2021 | BGNE | Buy Now | BeiGene | — | — | Andrew Berens49% | $388 → $417 | Maintains | Outperform | Get Alert |
| 06/11/2021 | FMTX | Buy Now | Forma Therapeutics Hldgs | — | — | Andrew Berens49% | $65 → $54 | Maintains | Outperform | Get Alert |
| 06/04/2021 | CGEM | Buy Now | Cullinan Oncology | $8.30 | 550.6% | Andrew Berens49% | $48 → $54 | Maintains | Outperform | Get Alert |
| 06/04/2021 | AZN | Buy Now | AstraZeneca | $72.60 | -11.85% | Andrew Berens49% | $63 → $64 | Maintains | Outperform | Get Alert |
| 05/07/2021 | EPZM | Buy Now | Epizyme | — | — | Andrew Berens49% | $12 → $16 | Upgrade | Market Perform → Outperform | Get Alert |
| 04/26/2021 | VIRX | Buy Now | Viracta Therapeutics | $0.03 | 71900% | Andrew Berens49% | → $18 | Initiates | → Outperform | Get Alert |
| 04/14/2021 | GBT | Buy Now | Global Blood Therapeutics | — | — | Andrew Berens49% | → $54 | Initiates | → Outperform | Get Alert |
| 04/13/2021 | ZNTL | Buy Now | Zentalis Pharma | $1.87 | 3322.46% | Andrew Berens49% | $60 → $64 | Maintains | Outperform | Get Alert |
| 03/16/2021 | MRUS | Buy Now | Merus | $46.98 | -29.76% | Andrew Berens49% | → $33 | Initiates | → Outperform | Get Alert |
| 03/11/2021 | AVEO | Buy Now | AVEO Pharmaceuticals | — | — | Andrew Berens49% | $10 → $18 | Maintains | Outperform | Get Alert |
| 03/02/2021 | AZN | Buy Now | AstraZeneca | $72.60 | -13.23% | Andrew Berens49% | $64 → $63 | Maintains | Outperform | Get Alert |
| 02/26/2021 | AGIO | Buy Now | Agios Pharmaceuticals | $30.50 | 63.93% | Andrew Berens49% | $55 → $50 | Downgrade | Outperform → Market Perform | Get Alert |
| 02/25/2021 | ZYME | Buy Now | Zymeworks | $12.80 | 220.31% | Andrew Berens49% | $50 → $41 | Downgrade | Outperform → Market Perform | Get Alert |
| 02/12/2021 | SGEN | Buy Now | Seagen | — | — | Andrew Berens49% | $200 → $192 | Maintains | Outperform | Get Alert |
| 02/10/2021 | INCY | Buy Now | Incyte | $62.08 | 12.76% | Andrew Berens49% | $89 → $70 | Downgrade | Market Perform → Underperform | Get Alert |
| 02/10/2021 | DCPH | Buy Now | Deciphera Pharmaceuticals | — | — | Andrew Berens49% | → $70 | Upgrade | Market Perform → Outperform | Get Alert |
| 02/02/2021 | CGEM | Buy Now | Cullinan Oncology | $8.30 | 526.51% | Andrew Berens49% | → $52 | Initiates | → Outperform | Get Alert |
| 01/27/2021 | AGIO | Buy Now | Agios Pharmaceuticals | $30.50 | 80.33% | Andrew Berens49% | $51 → $55 | Maintains | Outperform | Get Alert |
| 01/19/2021 | AVEO | Buy Now | AVEO Pharmaceuticals | — | — | Andrew Berens49% | $7 → $10 | Maintains | Outperform | Get Alert |
| 01/12/2021 | BPMC | Buy Now | Blueprint Medicines | $93.08 | 36.44% | Andrew Berens49% | $121 → $127 | Maintains | Outperform | Get Alert |
| 01/12/2021 | ZYME | Buy Now | Zymeworks | $12.80 | 415.63% | Andrew Berens49% | $45 → $66 | Maintains | Outperform | Get Alert |
| 12/16/2020 | COGT | Buy Now | Cogent Biosciences | $7.02 | 184.9% | Andrew Berens49% | → $20 | Initiates | → Outperform | Get Alert |
| 12/14/2020 | TPTX | Buy Now | Turning Point | — | — | Andrew Berens49% | $116 → $127 | Maintains | Outperform | Get Alert |
| 12/09/2020 | AGIO | Buy Now | Agios Pharmaceuticals | $30.50 | 100% | Andrew Berens49% | $67 → $61 | Maintains | Outperform | Get Alert |
| 12/08/2020 | FMTX | Buy Now | Forma Therapeutics Hldgs | — | — | Andrew Berens49% | $54 → $65 | Maintains | Outperform | Get Alert |
| 11/19/2020 | BGNE | Buy Now | BeiGene | — | — | Andrew Berens49% | $240 → $327 | Maintains | Outperform | Get Alert |
| 11/12/2020 | DCPH | Buy Now | Deciphera Pharmaceuticals | — | — | Andrew Berens49% | $58 → $70 | Maintains | Market Perform | Get Alert |
| 11/06/2020 | BGNE | Buy Now | BeiGene | — | — | Andrew Berens49% | $210 → $240 | Maintains | Outperform | Get Alert |
| 11/06/2020 | CLVS | Buy Now | Clovis Oncology | — | — | Andrew Berens49% | $4 → $3 | Maintains | Underperform | Get Alert |
| 10/30/2020 | SGEN | Buy Now | Seagen | — | — | Andrew Berens49% | $204 → $200 | Maintains | Outperform | Get Alert |
| 10/26/2020 | MRTX | Buy Now | Mirati Therapeutics | — | — | Andrew Berens49% | $134 → $195 | Maintains | Outperform | Get Alert |
| 10/26/2020 | TPTX | Buy Now | Turning Point | — | — | Andrew Berens49% | $77 → $116 | Maintains | Outperform | Get Alert |
| 10/19/2020 | AGIO | Buy Now | Agios Pharmaceuticals | $30.50 | 119.67% | Andrew Berens49% | $72 → $67 | Maintains | Outperform | Get Alert |
| 10/13/2020 | BPMC | Buy Now | Blueprint Medicines | $93.08 | 7.43% | Andrew Berens49% | $92 → $100 | Maintains | Overweight | Get Alert |
| 10/12/2020 | SGEN | Buy Now | Seagen | — | — | Andrew Berens49% | $187 → $204 | Maintains | Outperform | Get Alert |
| 09/22/2020 | SGEN | Buy Now | Seagen | — | — | Andrew Berens49% | $185 → $187 | Maintains | Outperform | Get Alert |
| 09/15/2020 | SGEN | Buy Now | Seagen | — | — | Andrew Berens49% | $173 → $185 | Maintains | Outperform | Get Alert |
| 09/14/2020 | DCPH | Buy Now | Deciphera Pharmaceuticals | — | — | Andrew Berens49% | $54 → $58 | Maintains | Market Perform | Get Alert |
| 08/13/2020 | AVEO | Buy Now | AVEO Pharmaceuticals | — | — | Andrew Berens49% | → $7 | Initiates | → Outperform | Get Alert |
| 08/06/2020 | ZYME | Buy Now | Zymeworks | $12.80 | 251.56% | Andrew Berens49% | → $45 | Initiates | → Outperform | Get Alert |
| 08/05/2020 | DCPH | Buy Now | Deciphera Pharmaceuticals | — | — | Andrew Berens49% | $55 → $54 | Maintains | Market Perform | Get Alert |
| 08/04/2020 | INCY | Buy Now | Incyte | $62.08 | 40.14% | Andrew Berens49% | $86 → $87 | Maintains | Market Perform | Get Alert |
| 07/31/2020 | SGEN | Buy Now | Seagen | — | — | Andrew Berens49% | $167 → $173 | Maintains | Outperform | Get Alert |
| 07/27/2020 | BPMC | Buy Now | Blueprint Medicines | $93.08 | 14.95% | Andrew Berens49% | $106 → $107 | Maintains | Outperform | Get Alert |
| 07/15/2020 | BPMC | Buy Now | Blueprint Medicines | $93.08 | -1.16% | Andrew Berens49% | $88 → $92 | Maintains | Overweight | Get Alert |
| 07/15/2020 | BPMC | Buy Now | Blueprint Medicines | $93.08 | 13.88% | Andrew Berens49% | $105 → $106 | Maintains | Outperform | Get Alert |
| 07/14/2020 | FMTX | Buy Now | Forma Therapeutics Hldgs | — | — | Andrew Berens49% | → $54 | Initiates | → Outperform | Get Alert |
| 06/30/2020 | SGEN | Buy Now | Seagen | — | — | Andrew Berens49% | $155 → $167 | Maintains | Outperform | Get Alert |
| 06/19/2020 | EPZM | Buy Now | Epizyme | — | — | Andrew Berens49% | $18 → $16 | Maintains | Market Perform | Get Alert |
| 06/15/2020 | AGIO | Buy Now | Agios Pharmaceuticals | $30.50 | 136.07% | Andrew Berens49% | $70 → $72 | Maintains | Outperform | Get Alert |
| 06/03/2020 | BGNE | Buy Now | BeiGene | — | — | Andrew Berens49% | $207 → $210 | Maintains | Outperform | Get Alert |
| 05/29/2020 | AZN | Buy Now | AstraZeneca | $72.60 | -10.47% | Andrew Berens49% | $60 → $65 | Maintains | Outperform | Get Alert |
| 05/20/2020 | CLVS | Buy Now | Clovis Oncology | — | — | Andrew Berens49% | $5 → $4 | Maintains | Underperform | Get Alert |
| 05/13/2020 | TPTX | Buy Now | Turning Point | — | — | Andrew Berens49% | $60 → $67 | Maintains | Outperform | Get Alert |
| 05/01/2020 | SGEN | Buy Now | Seagen | — | — | Andrew Berens49% | $146 → $155 | Maintains | Outperform | Get Alert |
| 04/30/2020 | BPMC | Buy Now | Blueprint Medicines | $93.08 | -5.46% | Andrew Berens49% | $103 → $88 | Maintains | Overweight | Get Alert |
| 04/29/2020 | DCPH | Buy Now | Deciphera Pharmaceuticals | — | — | Andrew Berens49% | $50 → $55 | Maintains | Market Perform | Get Alert |
| 04/29/2020 | BPMC | Buy Now | Blueprint Medicines | $93.08 | 12.81% | Andrew Berens49% | $125 → $105 | Maintains | Outperform | Get Alert |
| 04/28/2020 | ZNTL | Buy Now | Zentalis Pharma | $1.87 | 2306.42% | Andrew Berens49% | → $45 | Initiates | → Outperform | Get Alert |
| 04/27/2020 | CLVS | Buy Now | Clovis Oncology | — | — | Andrew Berens49% | → $5 | Downgrade | Market Perform → Underperform | Get Alert |
| 04/20/2020 | SGEN | Buy Now | Seagen | — | — | Andrew Berens49% | $138 → $146 | Maintains | Outperform | Get Alert |
| 02/18/2020 | BPMC | Buy Now | Blueprint Medicines | $93.08 | 10.66% | Andrew Berens49% | $108 → $103 | Maintains | Overweight | Get Alert |
| 11/22/2019 | AZN | Buy Now | AstraZeneca | $72.60 | — | Andrew Berens49% | — | Initiates | → Outperform | Get Alert |
| 11/06/2019 | BPMC | Buy Now | Blueprint Medicines | $93.08 | 16.03% | Andrew Berens49% | $109 → $108 | Maintains | Overweight | Get Alert |
| 10/29/2019 | DCPH | Buy Now | Deciphera Pharmaceuticals | — | — | Andrew Berens49% | — | Upgrade | Underperform → Market Perform | Get Alert |
| 10/11/2019 | BPMC | Buy Now | Blueprint Medicines | $93.08 | 17.1% | Andrew Berens49% | $110 → $109 | Maintains | Overweight | Get Alert |
| 09/24/2019 | CLVS | Buy Now | Clovis Oncology | — | — | Andrew Berens49% | — | Downgrade | Outperform → Market Perform | Get Alert |
| 05/13/2019 | HOOK | Buy Now | HOOKIPA Pharma | $1.20 | 1566.53% | Andrew Berens49% | → $200 | Initiates | → Outperform | Get Alert |
| 05/13/2019 | TPTX | Buy Now | Turning Point | — | — | Andrew Berens49% | → $42 | Initiates | → Outperform | Get Alert |
| 04/03/2019 | BPMC | Buy Now | Blueprint Medicines | $93.08 | 20.33% | Andrew Berens49% | → $112 | Initiates | → Overweight | Get Alert |
| 11/05/2018 | EPZM | Buy Now | Epizyme | — | — | Andrew Berens49% | $12 → $11 | Maintains | Equal-Weight | Get Alert |
| 09/07/2018 | NBRV | Buy Now | Nabriva Therapeutics | — | — | Andrew Berens49% | → $2000 | Reinstates | → Overweight | Get Alert |
| 09/07/2018 | EPZM | Buy Now | Epizyme | — | — | Andrew Berens49% | → $12 | Reinstates | → Equal-Weight | Get Alert |
| 07/13/2018 | INCY | Buy Now | Incyte | $62.08 | — | Andrew Berens49% | — | Downgrade | Overweight → Equal-Weight | Get Alert |
| 04/10/2018 | INCY | Buy Now | Incyte | $62.08 | 22.42% | Andrew Berens49% | $142 → $76 | Maintains | Overweight | Get Alert |
| 03/21/2018 | SGEN | Buy Now | Seagen | — | — | Andrew Berens49% | $69 → $67 | Maintains | Overweight | Get Alert |
| 03/01/2018 | TSRO | Buy Now | Tesaro | — | — | Andrew Berens49% | $156 → $146 | Maintains | Overweight | Get Alert |
| 01/17/2018 | NBRV | Buy Now | Nabriva Therapeutics | — | — | Andrew Berens49% | → $2500 | Initiates | → Overweight | Get Alert |
| 01/10/2018 | EPZM | Buy Now | Epizyme | — | — | Andrew Berens49% | → $20 | Initiates | → Overweight | Get Alert |
| 11/08/2017 | TSRO | Buy Now | Tesaro | — | — | Andrew Berens49% | $181 → $165 | Maintains | Overweight | Get Alert |
| 11/02/2017 | CLVS | Buy Now | Clovis Oncology | — | — | Andrew Berens49% | $89 → $86 | Maintains | Overweight | Get Alert |
| 10/31/2017 | SGEN | Buy Now | Seagen | — | — | Andrew Berens49% | $64 → $69 | Maintains | Overweight | Get Alert |
| 10/23/2017 | BPMC | Buy Now | Blueprint Medicines | $93.08 | -16.2% | Andrew Berens49% | $45 → $78 | Maintains | Overweight | Get Alert |
| 09/22/2017 | VSAR | Buy Now | Versartis | — | — | Andrew Berens49% | $102 → $18 | Maintains | Equal-Weight | Get Alert |
| 09/22/2017 | ICPT | Buy Now | Intercept Pharma | — | — | Andrew Berens49% | $75 → $50 | Maintains | Underweight | Get Alert |
| 07/14/2017 | OCUL | Buy Now | Ocular Therapeutix | $7.53 | 6.24% | Andrew Berens49% | $16 → $8 | Maintains | Equal-Weight | Get Alert |
| 06/23/2017 | OCUL | Buy Now | Ocular Therapeutix | $7.53 | — | Andrew Berens49% | — | Downgrade | Overweight → Equal-Weight | Get Alert |
| 02/15/2017 | BPMC | Buy Now | Blueprint Medicines | $93.08 | — | Andrew Berens49% | — | Initiates | → Overweight | Get Alert |
| 01/13/2017 | TSRO | Buy Now | Tesaro | — | — | Andrew Berens49% | — | Initiates | → Overweight | Get Alert |
| 01/13/2017 | CLVS | Buy Now | Clovis Oncology | — | — | Andrew Berens49% | — | Initiates | → Overweight | Get Alert |
| 06/07/2016 | OCUL | Buy Now | Ocular Therapeutix | $7.53 | 112.48% | Andrew Berens49% | $17 → $16 | Maintains | Overweight | Get Alert |
| 05/31/2016 | ICPT | Buy Now | Intercept Pharma | — | — | Andrew Berens49% | → $80 | Maintains | Underweight | Get Alert |
| 04/28/2016 | OCUL | Buy Now | Ocular Therapeutix | $7.53 | 125.76% | Andrew Berens49% | $15 → $17 | Maintains | Overweight | Get Alert |
| 04/08/2016 | ICPT | Buy Now | Intercept Pharma | — | — | Andrew Berens49% | $100 → $80 | Downgrade | Equal-Weight → Underperform | Get Alert |
| 02/18/2016 | OCUL | Buy Now | Ocular Therapeutix | $7.53 | 99.2% | Andrew Berens49% | → $15 | Upgrade | Equal-Weight → Overweight | Get Alert |
| 02/17/2016 | OCUL | Buy Now | Ocular Therapeutix | $7.53 | 99.2% | Andrew Berens49% | → $15 | Upgrade | Equal-Weight → Overweight | Get Alert |
| 01/29/2016 | ICPT | Buy Now | Intercept Pharma | — | — | Andrew Berens49% | → $100 | Upgrade | Underweight → Equal-Weight | Get Alert |
| 08/13/2015 | ICPT | Buy Now | Intercept Pharma | — | — | Andrew Berens49% | → $165 | Initiates | → Underweight | Get Alert |
| 08/13/2015 | VSAR | Buy Now | Versartis | — | — | Andrew Berens49% | → $102 | Initiates | → Equal-Weight | Get Alert |
| 08/13/2015 | OCUL | Buy Now | Ocular Therapeutix | $7.53 | 218.73% | Andrew Berens49% | → $24 | Initiates | → Equal-Weight | Get Alert |
| 04/15/2014 | VSAR | Buy Now | Versartis, Inc. | — | — | Andrew Berens49% | → $474 | Initiates | → Overweight | Get Alert |
| 02/04/2014 | TSRO | Buy Now | TESARO, Inc. | — | — | Andrew Berens49% | $45 → $30 | Downgrade | Overweight → Equal-weight | Get Alert |
| 07/23/2012 | TSRO | Buy Now | Tesaro | — | — | Andrew Berens49% | → $19 | Initiates | → Overweight | Get Alert |
